Kevin Fitzpatrick

Title: Kevin Fitzpatrick: Innovator in Pharmaceutical Formulations

Introduction

Kevin Fitzpatrick is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the preparation of polymorphic mixtures for medicinal applications. His innovative work has the potential to enhance drug treatment options.

Latest Patents

Kevin Fitzpatrick holds a patent for "Pharmaceutical salt forms of Cepharanthine and Tetrandrine." This patent relates to the preparation of polymorphic mixtures of Cepharanthine.2HCl. The invention involves forming mixtures of at least two polymorphic forms into a mobile liquid phase in organic/aqueous solvent mixtures, along with enteric polymer. These mixtures can be spray dried to produce solid particulate enteric formulations for medicinal drug-treatment applications.

Career Highlights

Kevin Fitzpatrick is associated with the Southwest Research Institute, where he has been involved in groundbreaking research and development. His work focuses on improving pharmaceutical formulations, which can lead to better therapeutic outcomes for patients.

Collaborations

Throughout his career, Kevin has collaborated with esteemed colleagues, including William E. Bauta and Joseph A. McDonough. These collaborations have contributed to the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

Kevin Fitzpatrick's contributions to pharmaceutical innovations demonstrate his commitment to enhancing drug treatment methodologies. His work continues to impact the field positively, paving the way for future advancements in medicinal formulations.